Blue Oak Pharmaceuticals is committed to finding the next generation of drugs for brain disorders. We believe that first-in-class drugs will be discovered by integrating novel, custom-designed privileged chemotypes with validated in vivo systems neurobiology assays and brain circuit imaging. Blue Oak drug hunters are experts in the systems neurobiology of brain disorders, medicinal chemistry and informatics. Our industry-leading productivity integrates a “global research team” that integrates established partners with cutting-edge technologies in behavioral profiling, synthetic chemistry and brain imaging. We advance first-in-class clinical candidates to early phase proof-of-concept studies using translational medicine biomarkers for brain circuit activity.